Media Pack
News

Current Edition

Volume 16 Issue 3
 
 
FDA Efficacy Recommendations Vary for Hypogonadotropic Hypogonadism Drugs
Volume 10 Issue 2

FDA Efficacy Recommendations Vary for Hypogonadotropic Hypogonadism Drugs

This article, written by Meg Egan Auderset at Clarivate Analytics, describes how the new draft industry guidance from the US Food and Drug Administration (FDA) unders...
5 April 2018 Volume 10 Issue 2
Continue Reading →
Ensuring Launch Success in Rare Disease Areas by Creating a Value Story
Volume 10 Issue 2

Ensuring Launch Success in Rare Disease Areas by Creating a Value Story

A number of trends (both in science and on the regulatory front) bode well for the development and availability of drugs to treat rare diseases. The authors Cinzia Do...
5 April 2018 Volume 10 Issue 2
Continue Reading →
Clinical Trials in Russia – Report on Q3 of 2017
Volume 10 Issue 2

Clinical Trials in Russia – Report on Q3 of 2017

The Russian MoH approved 158 new clinical trials of all types including local and bioequivalence studies during Q3 2017, demonstrating a 34% decrease in comparison wi...
5 April 2018 Volume 10 Issue 2
Continue Reading →
Combined Studies Under the New EU Clinical Trial Regulation
Volume 10 Issue 2

Combined Studies Under the New EU Clinical Trial Regulation

The key aim of the new EU Clinical Trial Regulation, which is currently planned for implementation in mid-2019, is to boost clinical research in the European Union (E...
5 April 2018 Volume 10 Issue 2
Continue Reading →
Paediatric Melanoma and the Pharmaceutical Industry
Volume 10 Issue 2

Paediatric Melanoma and the Pharmaceutical Industry

The age of paediatric melanoma used to be a theoretical discussion, but has become a real-life challenge due to arbitrary age limits decreed by regulatory authorities...
5 April 2018 Volume 10 Issue 2 European Medicines Agency | melanoma
Continue Reading →
A Review of FDA’s Updated Guidance for Developing Drugs to Treat Early Alzheimer’s Disease
Volume 10 Issue 2

A Review of FDA’s Updated Guidance for Developing Drugs to Treat Early Alzheimer’s Disease

There has been a renewed interest in clinical trials of drugs to treat early Alzheimer’s disease, owing partially to recent advances in the understanding of pathophys...
5 April 2018 Volume 10 Issue 2
Continue Reading →
Clinical Trials Down Under Australia and New Zealand – A Competitive Region
Volume 10 Issue 2

Clinical Trials Down Under Australia and New Zealand – A Competitive Region

The Australian clinical trials landscape has developed considerably over recent years with over 1000 new clinical trials commencing each year in the pharmaceutical, b...
5 April 2018 Volume 10 Issue 2
Continue Reading →
Russian Clinical Trials Market in 2017
Volume 10 Issue 2

Russian Clinical Trials Market in 2017

Following on from the last article featured by Svetlana Zavidova from the Association of Clinical Trials Organizations (ACTO) in the July 2017 JCS on clinical trials ...
5 April 2018 Volume 10 Issue 2
Continue Reading →
Developing Talent for the Future of Clinical Research
Volume 10 Issue 2

Developing Talent for the Future of Clinical Research

Clinical research is a rapidly evolving and dynamic environment and the sector is undergoing significant changes on a number of fronts. The wider use of technology, r...
5 April 2018 Volume 10 Issue 2
Continue Reading →
How to Rescue a Clinical Trial, if You Must
Volume 10 Issue 2

How to Rescue a Clinical Trial, if You Must

Conducting a clinical trial is a huge and complex undertaking, and there are, more often than not, challenges. And in an undertaking as scientifically and logisticall...
5 April 2018 Volume 10 Issue 2
Continue Reading →
 
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte